• 1. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 2. An investigation on the second-order nonlinear optical response of cationic bipyridine or phenanthroline iridium(iii) complexes bearing cyclometallated 2-phenylpyridines with a triphenylamine substituent?
  David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 5. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Toluenes

2,2,2-Trifluoro-1-(6-methylpyridin-2-yl)ethan-1-ol

The compound 2,2,2-trifluoro-1-(6-methylpyridin-2-yl)ethan-1-ol (CAS No. 2091376-51-9) is a highly specialized organic compound with significant applications in the fields of pharmaceuticals and agrochemicals. This compound is characterized by its unique structure, which combines a trifluoroethyl group with a substituted pyridine ring. The trifluoroethyl group contributes to the compound's stability and lipophilicity, while the pyridine ring provides a platform for further functionalization and biological activity.

Recent studies have highlighted the importance of fluorinated alcohols like this compound in drug design. Fluorine substitution is known to enhance the bioavailability and metabolic stability of molecules, making them more suitable for therapeutic applications. The trifluoroethyl alcohol moiety in this compound is particularly valuable due to its ability to modulate physicochemical properties such as solubility and permeability.

The 6-methylpyridin-2-yl substituent adds another layer of complexity to the molecule. Pyridine derivatives are widely used in medicinal chemistry due to their ability to act as hydrogen bond donors and acceptors, which are critical for molecular recognition and binding. The methyl group at position 6 of the pyridine ring further enhances the molecule's stability and may influence its pharmacokinetic profile.

From a synthetic perspective, the preparation of 2,2,2-trifluoro-1-(6-methylpyridin-2-yl)ethan-1-ol involves a multi-step process that typically begins with the synthesis of the pyridine derivative. This is followed by nucleophilic substitution or coupling reactions to introduce the trifluoroethyl group. Recent advancements in catalytic methods have made these transformations more efficient and environmentally friendly.

In terms of applications, this compound has shown promise in various biological assays. For instance, it has been evaluated for its potential as an antimicrobial agent, where its fluorinated structure contributes to enhanced activity against bacterial pathogens. Additionally, it has been explored as a lead compound in the development of new drugs targeting specific enzyme systems or receptors.

One of the most exciting developments involving this compound is its role in structure-based drug design. Researchers have utilized computational methods to predict how modifications to the molecule could improve its binding affinity to target proteins. These studies have provided valuable insights into optimizing the compound's pharmacodynamic properties.

The integration of fluorinated alcohols into medicinal chemistry has opened new avenues for drug discovery. Compounds like 2,2,2-trifluoro-1-(6-methylpyridin-2-yl)ethan-1-ol exemplify how subtle structural changes can significantly impact a molecule's biological activity and therapeutic potential.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)